EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies

Stephan Steinke iD, Toni Kirmann iD, Eleonora A Loi, Jana Nerlich, Iron Weichard, Philipp Kuhn, Torsten Bullmann, Andreas Ritzau-Jost, Filiz Sila Rizalar, Harald Prüss, Volker Haucke, Christian Geis iD und 2 weitere

Brain · 02.05.2023 · 146 (5) · 1812-1820

DOI: 10.1093/brain/awac497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 03.03.2023. Verfasst von Stephan Steinke und 13 weiteren Autor:innen. Beteiligte Einrichtung: Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Department Medizinische Biotechnologie, Braunschweig 3…. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Encephalitis, Hashimoto Disease. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: German Research Foundation, European Research Council, German Ministry for Education and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N-methyl-D-aspartate receptor (NMDAR) encephalitis is the most common subtype of autoimmune encephalitis characterized by a complex neuropsychiatric syndrome usually including memory impairment. Patients develop an intrathecal immune response against NMDARs with antibodies that presumably bind to the amino-terminal domain of the GluN1 subunit. The therapeutic response to immunotherapy is often delayed. Therefore, new therapeutic approaches for fast neutralization of NMDAR antibodies are needed. Here, we developed fusion constructs consisting of the Fc part of immunoglobulin G and the amino-terminal domains of either GluN1 or combinations of GluN1 with GluN2A or GluN2B. Surprisingly, both GluN1 and GluN2 subunits were required to generate high-affinity epitopes. The construct with both subunits efficiently prevented NMDAR binding of patient-derived monoclonal antibodies and of patient CSF containing high-titre NMDAR antibodies. Furthermore, it inhibited the internalization of NMDARs in rodent dissociated neurons and human induced pluripotent stem cell-derived neurons. Finally, the construct stabilized NMDAR currents recorded in rodent neurons and rescued memory defects in passive-transfer mouse models using intrahippocampal injections. Our results demonstrate that both GluN1 and GluN2B subunits contribute to the main immunogenic region of the NMDAR and provide a promising strategy for fast and specific treatment of NMDAR encephalitis, which could complement immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsEncephalitisHashimoto DiseaseMiceAnimalsHumansReceptors, N-Methyl-D-AspartateAutoantibodies

Stichwörter der Autor:innen

NMDA receptorantibodies bodiesautoimmune encephalitismemorysynapses

Substanzen

Receptors, N-Methyl-D-AspartateAutoantibodies

Autor:innen und Institutionen

  • Technische Universität Braunschweig, Institut für Biochemie, Biotechnologie und Bioinformatik, Department Medizinische Biotechnologie, Braunschweig 38106, Germany.
  • Faculty of Medicine, Carl-Ludwig-Institute of Physiology, Leipzig University, Leipzig 04103, Germany.
  • Section Translational Neuroimmunology, Department for Neurology, Jena University Hospital, 07747 Jena, Germany.
  • YUMAB GmbH, Braunschweig 38124, Germany.
  • Department of Molecular Pharamcology and Cell Biology, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.
  • Faculty of Biology, Chemistry, Pharmacy, Freie Universität Berlin, Berlin 14195, Germany.

ORCID-Profile: Stephan Steinke, Toni Kirmann, Christian Geis, Michael Hust, Stefan Hallermann

Förderung

  • German Research Foundation
  • European Research Council
  • German Ministry for Education and Research
  • Helmholtz Association
  • Schilling foundation

Zitieren

APA

Steinke, S., Kirmann, T., Loi, E. A., Nerlich, J., Weichard, I., Kuhn, P., Bullmann, T., Ritzau-Jost, A., Rizalar, F. S., Prüss, H., Haucke, V., Geis, C., Hust, M., & Hallermann, S. (2023). NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies. Brain, 146(5), 1812-1820. https://doi.org/10.1093/brain/awac497

Vancouver

Steinke S, Kirmann T, Loi EA, Nerlich J, Weichard I, Kuhn P, et al. NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies. Brain. 2023;146(5):1812-1820. doi:10.1093/brain/awac497

BibTeX
@article{Steinke2023,
  author = {Steinke, Stephan and Kirmann, Toni and Loi, Eleonora A and Nerlich, Jana and Weichard, Iron and Kuhn, Philipp and Bullmann, Torsten and Ritzau-Jost, Andreas and Rizalar, Filiz Sila and Prüss, Harald and Haucke, Volker and Geis, Christian and Hust, Michael and Hallermann, Stefan},
  title = {NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies},
  journal = {Brain},
  year = {2023},
  volume = {146},
  number = {5},
  pages = {1812--1820},
  doi = {10.1093/brain/awac497}
}
Kostenlos starten →